Dr. Guenther Koehne, MD has an extensive clinical, translational and research program focused on relapsed multiple myeloma, relapsed/refractory myeloma, primary and secondary plasma cell leukemia. He has particular expertise in allogeneic (donor-derived) hematopoietic stem cell transplantation. At Memorial Sloan Kettering Cancer Center, he is pioneering a new type of stem cell transplantation in which we remove a specific subset of cells (T cells) from the donor’s stem cells before the transplant; this significantly reduces the so-called graft-versus-host reactions. As the principle investigator, he is leading several clinical trials to study the effectiveness of T cell-depleted transplants from related and unrelated donors in patients with high-risk multiple myeloma that incorporate myeloma-specific immunotherapies, including donor-derived myeloma-specific T-cell therapies and myeloma vaccine strategies.
Miami Cancer Institute:
8900 N Kendall Dr, Miami, FL 33176, USA
Get the latest thought leadership on Myeloma delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life
Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma
Thanks to our HealthTree Community for Myeloma Sponsors: